138 related articles for article (PubMed ID: 3094603)
1. Acute lymphoblastic leukemia and non-Hodgkin's lymphoma of T lineage: colony-forming cells retain growth factor (interleukin 2) dependence.
Touw I; Delwel R; van Zanen G; Löwenberg B
Blood; 1986 Nov; 68(5):1088-94. PubMed ID: 3094603
[TBL] [Abstract][Full Text] [Related]
2. Common and pre-B acute lymphoblastic leukemia cells express interleukin 2 receptors, and interleukin 2 stimulates in vitro colony formation.
Touw I; Delwel R; Bolhuis R; van Zanen G; Löwenberg B
Blood; 1985 Sep; 66(3):556-61. PubMed ID: 3161562
[TBL] [Abstract][Full Text] [Related]
3. Induction of IL-2 production, IL-2 receptor expression and proliferation of T3- T-PLL cells by phorbol ester.
Vyth-Dreese FA; De Vries JE
Int J Cancer; 1984 Dec; 34(6):831-8. PubMed ID: 6439651
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 2 stimulates chronic lymphocytic leukemia colony formation in vitro.
Touw I; Löwenberg B
Blood; 1985 Jul; 66(1):237-40. PubMed ID: 3873969
[TBL] [Abstract][Full Text] [Related]
5. Induction of phenotypic differentiation, interleukin 2 production, and PHA responsiveness of "immature" human thymocytes by interleukin 1 and phorbol ester.
de Vries JE; Vyth-Dreese FA; Figdor CG; Spits H; Leemans JM; Bont WS
J Immunol; 1983 Jul; 131(1):201-6. PubMed ID: 6408170
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of human T-cell leukemia/lymphoma virus in neoplastic T cells induced to proliferate by phorbol ester and interleukin-2.
Vyth-Dreese FA; de Vries JE
Int J Cancer; 1983 Jul; 32(1):53-9. PubMed ID: 6602780
[TBL] [Abstract][Full Text] [Related]
7. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F
Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211
[TBL] [Abstract][Full Text] [Related]
8. Idiotypic immunoglobulin secretion by human B cell non-Hodgkin's lymphomas is related to the expression of the interleukin-2 receptor.
Vyth-Dreese FA; Dellemijn TA; Hekman A; Melief CJ
Leukemia; 1988 Apr; 2(4):231-5. PubMed ID: 3129622
[TBL] [Abstract][Full Text] [Related]
9. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
10. T-cell colony formation in patients with T-cell malignancies: growth factor requirements for in-vitro proliferation of peripheral blood T-cell colony-forming cells.
Georgoulias V; Triebel F; Kosmatopoulos C; Allouche M; Gluckman JC; Mathe G; Jasmin C
Leuk Res; 1986; 10(4):419-27. PubMed ID: 3007873
[TBL] [Abstract][Full Text] [Related]
11. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
Tadmori W; Reed JC; Nowell PC; Kamoun M
J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
[TBL] [Abstract][Full Text] [Related]
12. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
Uckun FM; Myers DE; Ledbetter JA; Swaim SE; Gajl-Peczalska KJ; Vallera DA
J Immunol; 1988 Mar; 140(6):2103-11. PubMed ID: 3126241
[TBL] [Abstract][Full Text] [Related]
13. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
14. Growth requirements for human acute lymphoblastic leukemia cells: refinement of a clonogenic assay.
Estrov Z; Freedman MH
Cancer Res; 1988 Oct; 48(20):5901-7. PubMed ID: 3048651
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 responsiveness of immature T-cell colony-forming cells (T-CFC) from patients with acute T-cell lymphoblastic leukemias.
Georgoulias V; Allouche M; Salvatore A; Clemenceau C; Jasmin C
Cell Immunol; 1987 Apr; 105(2):317-31. PubMed ID: 3105894
[TBL] [Abstract][Full Text] [Related]
16. Lack of interleukin-2 (IL-2) dependent growth of TAC positive T-ALL/NHL cells is due to the expression of only low affinity receptors for IL-2.
Debatin KM; Woodroofe C; Lahm H; Fischer J; Falk W; Brandeis WE; Krammer PH
Leukemia; 1989 Aug; 3(8):566-71. PubMed ID: 2787451
[TBL] [Abstract][Full Text] [Related]
17. Phorbol ester induces interleukin-2 receptor on the cell surface of precursor thymocyte leukemia with no rearrangement of T cell receptor beta and gamma genes.
Morishima Y; Morishita Y; Adachi K; Tanimoto M; Ohno R; Saito H
Blood; 1987 Nov; 70(5):1291-6. PubMed ID: 2822168
[TBL] [Abstract][Full Text] [Related]
18. Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.
Zamkoff KW; Reeves WG; Paolozzi FP; Poiesz BJ; Comis RL; Tomar RH
Clin Immunol Immunopathol; 1985 Apr; 35(1):111-24. PubMed ID: 3922653
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of 12-tetradecanoylphorbol-13-acetate (TPA) and PHA as mitogens in the T-lymphocyte colony assay.
Winkelstein A; Simon PL; Myers PA; Weaver LD
Exp Hematol; 1986 Dec; 14(11):1023-8. PubMed ID: 3490990
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester induction of plasmacytoid and hairy cell leukemia features in B-type lymphocytic leukemias: the relation to B-cell differentiation and maturation.
Gazitt Y; Polliack A
Blood Cells; 1987; 12(2):413-39. PubMed ID: 3497682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
